Houston Public Media Moderna's COVID-19 Vaccine Becomes 2nd To Earn FDA Authorization Gulf Coast • Dec 19, 2020
Waco Tribune Herald Maryland U.S. Attorney's Office seizes two fake domain names Central Texas • Dec 18, 2020
Brenham Banner Press Aeglea BioTherapeutics Appoints Alison Lawton to Board of Directors Central Texas • Dec 17, 2020
Hays Free Press & Dripping Springs News Dispatch On vaccines, predictably, two lines form Central Texas • Dec 16, 2020
Brenham Banner Press Matica Biotechnology, Inc. Announces Plans to Construct GMP Facility for Viral Vector Production Central Texas • Dec 15, 2020
Waco Tribune Herald Indonesia expects halal certificate for experimental vaccine Central Texas • Dec 7, 2020
Wichita Falls Times Record News Panda Biotech moving equipment into new facility Northwest Texas • Dec 3, 2020
Brenham Banner Press Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of Homocystinuria Central Texas • Dec 1, 2020
Houston Public Media More Good News For Moderna's COVID-19 Vaccine Candidate Gulf Coast • Nov 30, 2020
KTTZ Radio Lubbock More Good News For Moderna's COVID-19 Vaccine Candidate High Plains • Nov 30, 2020
Brenham Banner Press Moderna to apply Monday for emergency use of its COVID-19 vaccine Central Texas • Nov 30, 2020
Brenham Banner Press Aeglea BioTherapeutics Announces New Presentation Time at Upcoming Investor Conference Central Texas • Nov 24, 2020
KTTZ Radio Lubbock FDA Grants Emergency Authorization For A Second COVID-19 Antibody Treatment High Plains • Nov 22, 2020
KTTZ Radio Lubbock Fauci: Vaccine Results Are 'Important Advance,' But Virus Precautions Are Still Vital High Plains • Nov 18, 2020
Brenham Banner Press Aeglea BioTherapeutics to Participate in Two Upcoming Virtual Investor Conferences Central Texas • Nov 17, 2020
Brenham Banner Press Moderna's COVID-19 vaccine 94.5 percent effective in Phase 3 study Central Texas • Nov 16, 2020
KTBB Radio Tyler Moderna's initial Phase 3 data shows its COVID-19 vaccine is up to 94.5% effective Upper East Texas • Nov 16, 2020
CBS Local Dallas Coronavirus Vaccine By Biotech Company Moderna Tests As 94.5% Effective In U.S. Trial Metroplex • Nov 16, 2020
Brenham Banner Press NANOSCOPE THERAPEUTICS Announces Presentation at the 2020 Annual Meeting of American Academy of Ophthalmology Central Texas • Nov 13, 2020